Literature DB >> 9217765

Multidrug resistance protein in recurrent breast cancer.

K Nooter, G B de la Riviere, J Klijn, G Stoter, J Foekens.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9217765     DOI： 10.1016/s0140-6736(05)63876-7

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  12 in total

Review 1.  Development of multidrug-resistance convertors: sense or nonsense?

Authors:  L van Zuylen; K Nooter; A Sparreboom; J Verweij
Journal:  Invest New Drugs       Date:  2000-08       Impact factor: 3.850

2.  Implantable hydrogel embedded dark-gold nanoswitch as a theranostic probe to sense and overcome cancer multidrug resistance.

Authors:  João Conde; Nuria Oliva; Natalie Artzi
Journal:  Proc Natl Acad Sci U S A       Date:  2015-03-02       Impact factor: 11.205

3.  Combined use of anticancer drugs and an inhibitor of multiple drug resistance-associated protein-1 increases sensitivity and decreases survival of glioblastoma multiforme cells in vitro.

Authors:  Lilia Peigñan; Wallys Garrido; Rodrigo Segura; Rómulo Melo; David Rojas; Juan Guillermo Cárcamo; Rody San Martín; Claudia Quezada
Journal:  Neurochem Res       Date:  2011-05-05       Impact factor: 3.996

4.  Multidrug-resistant protein-3 gene regulation by the transcription factor Nrf2 in human bronchial epithelial and non-small-cell lung carcinoma.

Authors:  Christopher M Mahaffey; Hongqiao Zhang; Alessandra Rinna; William Holland; Philip C Mack; Henry Jay Forman
Journal:  Free Radic Biol Med       Date:  2009-04-05       Impact factor: 7.376

5.  Oxazaphosphorine bioactivation and detoxification The role of xenobiotic receptors.

Authors:  Duan Wang; Hongbing Wang
Journal:  Acta Pharm Sin B       Date:  2012-04-01       Impact factor: 11.413

6.  Comparative evaluation by semiquantitative reverse transcriptase polymerase chain reaction of MDR1, MRP and GSTp gene expression in breast carcinomas.

Authors:  R Lacave; F Coulet; S Ricci; E Touboul; A Flahault; J G Rateau; D Cesari; J P Lefranc; J F Bernaudin
Journal:  Br J Cancer       Date:  1998-03       Impact factor: 7.640

Review 7.  Multidrug resistance associated proteins in multidrug resistance.

Authors:  Kamlesh Sodani; Atish Patel; Rishil J Kathawala; Zhe-Sheng Chen
Journal:  Chin J Cancer       Date:  2011-11-18

Review 8.  Multidrug resistance and cancer stem cells in neuroblastoma and hepatoblastoma.

Authors:  Anna Alisi; William C Cho; Franco Locatelli; Doriana Fruci
Journal:  Int J Mol Sci       Date:  2013-12-18       Impact factor: 5.923

9.  Chemotherapy induces Notch1-dependent MRP1 up-regulation, inhibition of which sensitizes breast cancer cells to chemotherapy.

Authors:  Baek Kim; Sam L Stephen; Andrew M Hanby; Kieran Horgan; Sarah L Perry; Julie Richardson; Elizabeth A Roundhill; Elizabeth M A Valleley; Eldo T Verghese; Bethany J Williams; James L Thorne; Thomas A Hughes
Journal:  BMC Cancer       Date:  2015-09-11       Impact factor: 4.430

10.  Regulation of Mucin 1 and multidrug resistance protein 1 by honokiol enhances the efficacy of doxorubicin-mediated growth suppression in mammary carcinoma cells.

Authors:  Padmamalini Thulasiraman; Andrea Butts Johnson
Journal:  Int J Oncol       Date:  2016-05-23       Impact factor: 5.650
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.